Cargando…

Novel SARS-CoV-2 therapeutic targets: RNA proofreading complex and virus-induced senescence

Detalles Bibliográficos
Autores principales:	Lin, Liangyu, Wang, Ying, Li, Qing, Hu, Mingyuan, Shi, Yufang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761837/ https://www.ncbi.nlm.nih.gov/pubmed/35039647 http://dx.doi.org/10.1038/s41418-021-00909-6

Ejemplares similares

Reconstitution and functional characterization of SARS-CoV-2 proofreading complex
por: Ma, Zhijun, et al.
Publicado: (2021)

Characterization of SARS-CoV-2 replication complex elongation and proofreading activity
por: Jones, Alisha N., et al.
Publicado: (2022)

Opportunities and Challenges in Targeting the Proofreading Activity of SARS-CoV-2 Polymerase Complex
por: Deval, Jerome, et al.
Publicado: (2022)

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2021)

Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN
por: Moeller, Nicholas H., et al.
Publicado: (2022)

SARS-CoV-2-induced senescence as a potential therapeutic target
por: Denholm, Mary, et al.
Publicado: (2022)

Structural basis of mismatch recognition by a SARS-CoV-2 proofreading enzyme
por: Liu, Chang, et al.
Publicado: (2021)

Syncytia formation during SARS-CoV-2 lung infection: a disastrous unity to eliminate lymphocytes
por: Lin, Liangyu, et al.
Publicado: (2021)

A Proofreading Mutation with an Allosteric Effect Allows a Cluster of SARS-CoV-2 Viruses to Rapidly Evolve
por: Mack, Andrew H, et al.
Publicado: (2023)

A Computational Study on the Interaction of NSP10 and NSP14: Unraveling the RNA Synthesis Proofreading Mechanism in SARS-CoV-2, SARS-CoV, and MERS-CoV
por: Sarma, Himakshi, et al.
Publicado: (2022)

Sofosbuvir terminated RNA is more resistant to SARS-CoV-2 proofreader than RNA terminated by Remdesivir
por: Jockusch, Steffen, et al.
Publicado: (2020)

Coupling of N7-methyltransferase and 3′-5′ exoribonuclease with SARS-CoV-2 polymerase reveals mechanisms for capping and proofreading
por: Yan, Liming, et al.
Publicado: (2021)

A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping
por: Romano, Maria, et al.
Publicado: (2020)

Antibodies and SARS-CoV-2: New Data on Diagnostics and Therapeutics
por: Focosi, Daniele, et al.
Publicado: (2022)

Sequence-specific and multiplex detection of COVID-19 virus (SARS-CoV-2) using proofreading enzyme-mediated probe cleavage coupled with isothermal amplification
por: Ding, Sheng, et al.
Publicado: (2021)

Handbook for proofreading
por: Anderson, Laura Killen 1938-
Publicado: (1994)

Origins of SARS-CoV-2: Focusing on Science
por: Shi, Zheng-Li
Publicado: (2021)

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
por: Robson, Fran, et al.
Publicado: (2020)

Coronavirus RNA Proofreading: Molecular Basis and Therapeutic Targeting
por: Robson, Fran, et al.
Publicado: (2020)

Virus against virus: a potential treatment for 2019-nCov (SARS-CoV-2) and other RNA viruses
por: Nguyen, Tuan M., et al.
Publicado: (2020)

Beyond SARS-CoV2, the role of viruses in the pathogenesis of hematologic malignancies
por: Wiestner, Adrian
Publicado: (2022)

SARS-CoV-2: To be or not to be vaccinated?
por: Beauchet, Olivier
Publicado: (2021)

SARS-CoV-2 docet
por: Sarli, Leopoldo
Publicado: (2021)

The grammar and proofreading course
por: Helling, Pamela
Publicado: (1992)

Molnupiravir’s mechanism of action drives “error catastrophe” in SARS-CoV-2: A therapeutic strategy that leads to lethal mutagenesis of the virus
por: Chatterjee, Srijan, et al.
Publicado: (2023)

Ivermectin, a new candidate therapeutic against SARS-CoV-2/COVID-19
por: Sharun, Khan, et al.
Publicado: (2020)

Second-Generation SARS-CoV-2 Recombinants: Lessons from Other Viruses
por: Focosi, Daniele, et al.
Publicado: (2023)

Analysis of critical protein–protein interactions of SARS-CoV-2 capping and proofreading molecular machineries towards designing dual target inhibitory peptides
por: Arabi-Jeshvaghani, Fatemeh, et al.
Publicado: (2023)

Is the Patient Infected with SARS-CoV-2?
por: Klausner, Jeffrey D., et al.
Publicado: (2021)

Fundamentals of SARS-CoV-2 Biosensors
por: Torres-Torres, Carlos, et al.
Publicado: (2022)

Terrific cells for SARS-CoV-2
por: Gottschalk, Stephen
Publicado: (2022)

Insights into RNA synthesis, capping, and proofreading mechanisms of SARS-coronavirus
por: Sevajol, Marion, et al.
Publicado: (2014)

Proofreading of Peptide—MHC Complexes through Dynamic Multivalent Interactions
por: Thomas, Christoph, et al.
Publicado: (2017)

SARS-CoV-2 Infection Causes Dopaminergic Neuron Senescence
por: Han, Yuling, et al.
Publicado: (2021)

Music of Microbiota Against SARS CoV-2
por: Belojevic, Goran, et al.
Publicado: (2019)

Focus on SARS-CoV-2 and COVID-19
por: Chen, Sharon C-A., et al.
Publicado: (2020)

In Pursuit of a SARS-CoV-2 Vaccine
por: Johnson, Alton R., et al.
Publicado: (2020)

Mental health and the SARS-CoV-2 pandemic
por: Crespo-Facorro, Benedicto
Publicado: (2020)

SARS-CoV2 vaccines: Slow is fast
por: Green, Douglas R.
Publicado: (2020)

SARS-CoV-2: Herausforderung für alle
por: Holz, Frank G.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_6gv37boodqic7ca60bj9cp55jm